{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-036829","form_type":"8-K","ticker":"AGEN","cik":"0001098972","company_name":"AGENUS INC","filed_at":"2025-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.929050+00:00","generated_at":"2026-05-24T23:11:29.492821+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Agenus Q4 net loss $46.8M; targets annual cash burn of ~$50M by mid-2025","bullets":["Q4 2024 net loss $46.8M ($2.04/share); full-year net loss $232.3M ($10.59/share).","Revenue Q4 $26.8M, full-year $103.5M (largely non-cash royalty).","Cash balance $40.4M at Dec 31, 2024, down from $76.1M year-end 2023.","Operational cash burn $28.7M in Q4; plan to cut annualized burn to ~$50M by mid-2025.","BOT/BAL program shows durable responses in colorectal cancer; partnership discussions ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-036829","json":"https://secwatch.observer/filing/0000950170-25-036829.json","markdown":"https://secwatch.observer/filing/0000950170-25-036829.md","text":"https://secwatch.observer/filing/0000950170-25-036829.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098972/000095017025036829/0000950170-25-036829-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098972/000095017025036829/agen-20250311.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T23:11:29.492821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}